Shionogi & Co Ltd

Common Name

Shionogi & Co

Country

Japan

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

4,955

Ticker

4507

Exchange

Japan Exchange Group

Website

www.shionogi.com

Description

Shionogi & Co., Ltd. is a leading pharmaceutical company specializing in the research, development, and distribution of pharmaceutical products. Established in Japan in 1878, Shionogi focuses primaril... Show more

Income Statement Balance Sheet

Shionogi & Co's Financial Statements Preview

Below are the financial statements of Shionogi & Co, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in billions of JPY	2024 as of 2024-03-31	2023 as of 2023-03-31
Assets	—	—
Non-current assets	—	—
Property, plant and equipment	114.59^a	112.09^a
Goodwill	15.29^a	9.82^a
Intangible assets	117.62^a	96.31^a
Right-of-use assets	9.44^a	6.48^a
Investment property	27.77^a	26.38^a
Other financial assets	292.32^a	247.71^a
Deferred tax assets	13.53^a	22.1^a
Other non-current assets	42.16^a	6.72^a
Total non-current assets	632.71^a	527.61^a
Current assets	—	—
Inventories	64.92^a	57.92^a
Trade receivables	122.83^a	109.77^a
Other financial assets	215.76^a	254.13^a
Other current assets	22.61^a	53.14^a
Cash and cash equivalents	358.09^a	309.22^a
Total current assets	784.21^a	784.19^a
Total assets	1,416.92^a	1,311.8^a
Equity and liabilities	—	—
Equity	—	—
Share capital	21.28^a	21.28^a
Capital surplus	14.24^a	15.2^a
Treasury shares	-137.89^a	-63.07^a
Retained earnings	1,065.91^a	940.61^a
Other components of equity	271.78^a	186.03^a
Equity attributable to owners of parent	1,235.33^a	1,100.05^a
Non-controlling interests	17.24^a	21.83^a
Total equity	1,252.56^a	1,121.88^a
Liabilities	—	—
Non-current liabilities	—	—
Lease liabilities	8.75^a	6.4^a
Other financial liabilities	7.65^a	4.84^a
Retirement benefit liability	7.99^a	12.87^a
Deferred tax liabilities	4.36^a	5.92^a
Other non-current liabilities	1.69^a	1.34^a
Total non-current liabilities	30.45^a	31.37^a
Current liabilities	—	—
Lease liabilities	2.87^a	3.01^a
Trade payables	14.81^a	14.01^a
Other financial liabilities	31.12^a	29.72^a
Income taxes payable	20.84^a	42.22^a
Other current liabilities	64.27^a	69.6^a
Total current liabilities	133.91^a	158.55^a
Total liabilities	164.36^a	189.92^a
Total equity and liabilities	1,416.92^a	1,311.8^a

Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources

pro

Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.

Download granular datasets (CSV/XLS)

Access underlying corporate disclosures (PDF)

Trace all values back to their original sources

Start Your 30-Day Free Trial

Formats Included

Excel

CSV

Json

All data fully traceable to original sources

Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Shionogi & Co’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Shionogi & Co's Integrated Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Shionogi & Co Ltd

Shionogi & Co's Financial Statements Preview

Verified Sources Behind Shionogi & Co’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Kyowa Kirin Co Ltd

Eisai Co Ltd

Ipsen SA

Neurocrine Biosciences Inc

Swedish Orphan Biovitrum AB (publ)

Cipla Ltd

Account Restricted